• Lactobacillus gasseri ATCC33323 Modulates Colitis via NR1I3–

  2026-07-08

  Qian et al. (2024) reveal that Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice by enhancing intestinal barrier integrity through NR1I3-mediated regulation of E-cadherin. Their mechanistic and genetic insights highlight new probiotic therapeutic avenues for IBD and offer a technical foundation for advanced mucosal research.

• 3D Nanotube-in-Micropillar Electrodes Enable Blood Cell Elec

  2026-07-07

  This study introduces a robust three-dimensional nanotube-in-micropillar electrode array for size-independent electroporation of blood cells, overcoming challenges of heterogeneous cell populations. The platform demonstrates high transfection efficiency and viability, supporting non-viral mRNA delivery for blood cell-based therapies.

• CKI 7 Dihydrochloride: Precision-Driven CK1 Inhibition in Tr

  2026-07-07

  Explore the mechanistic and translational significance of CKI 7 dihydrochloride as a selective Casein kinase 1 inhibitor. This article provides actionable insights for researchers targeting Wnt signaling, circadian regulation, and metastatic cancer pathways, integrating recent advances on phosphorylation-dependent metastasis suppression with practical guidance for workflow optimization.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-07-06

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of high-resolution separation of low molecular weight proteins and peptides (1–10 kDa), especially where conventional Tris-glycine SDS-PAGE is inadequate. It is intended for research workflows involving small protein or peptide analysis and is not appropriate for diagnostic or clinical applications.

• (-)-JQ1 in BET Bromodomain Research: Beyond the Negative Con

  2026-07-06

  Explore the nuanced role of (-)-JQ1, a JQ1 stereoisomer, in epigenetics research and advanced cancer biology studies. This article offers a deep dive into control compound design, protocol implications, and new insights from recent BET inhibition research.

• GLT-1 Upregulation Mitigates Neuronal Loss via CB1-CREB Path

  2026-07-05

  This study demonstrates that GLT-1 upregulation, achieved through CB1 cannabinoid receptor antagonism, significantly reduces neuronal apoptosis and cognitive dysfunction after traumatic brain injury in mice. The findings provide mechanistic insight into glutamate homeostasis restoration and highlight the CB1-CREB-GLT-1 axis as a promising therapeutic target.

• MG-132 (Z-LLL-al): Proteasome Inhibitor Mechanisms & Benchma

  2026-07-04

  MG-132 (Z-LLL-al) is a potent, cell-permeable peptide aldehyde proteasome inhibitor widely used in apoptosis and cell cycle arrest studies. Its high selectivity and nanomolar potency enable rigorous investigation of oxidative stress and protein degradation pathways in cancer research. This article provides evidence-backed protocols, mechanistic insights, and critical limitations for MG-132, as supplied by APExBIO.

• Platycodin D Targets RFC4 to Induce Apoptosis in NSCLC Cells

  2026-07-03

  This study uncovers how Platycodin D (PD) induces apoptosis in non-small cell lung cancer (NSCLC) by binding to RFC4 and disrupting the Notch signaling axis. Using multidimensional proteomics, the authors provide mechanistic insight into PD's action and highlight new opportunities for targeted apoptotic therapies and epigenetic research in oncology.

• Disodium Bicinchoninate: Aqueous Chelation for Next-Gen Bioc

  2026-07-03

  Explore how Disodium bicinchoninate, a highly water-soluble molecular biology reagent, advances aqueous chelation and assay reliability. This article offers new insights into its mechanism and strategic applications, setting it apart from prior content.

• Standardized Whole-Blood Stimulation Reveals Immunometabolic

  2026-07-02

  This paper introduces a reproducible protocol for analyzing human immune responses using standardized whole-blood stimulation under metabolic modulation. By systematically integrating metabolic inhibitors, the study provides a robust platform for dissecting how metabolic pathways—including fatty acid oxidation—influence cytokine production, with implications for immunometabolism and metabolic disorder research.

• BMS-345541 Hydrochloride: Reliable IKK Inhibitor for NF-κB R

  2026-07-02

  This article offers an evidence-based, scenario-driven exploration of BMS-345541 hydrochloride (SKU A3248), a highly selective IKK inhibitor. It addresses common laboratory challenges in cell signaling and viability assays, guiding researchers through protocol optimization, data interpretation, and reliable sourcing. The content supports reproducibility and informed vendor selection for advanced inflammation and cancer biology research.

• Pharmacokinetics of Corydalis saxicola Alkaloids in MASH: Tr

  2026-07-01

  This study systematically characterizes how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of key alkaloids from Corydalis saxicola Bunting. By elucidating the interplay between disease state, drug-metabolizing enzymes, and transporter expression, the findings inform rational dosing strategies for MASLD/MASH treatment.

• Lipid Nanoparticle-Mediated mRNA Delivery to Islet β Cells i

  2026-07-01

  Enriquez et al. introduce a conjugated lipid nanoparticle (LNP) platform for targeted delivery of mRNA to pancreatic islet β cells, with a focus on type 1 diabetes models. Their work demonstrates both enhanced cellular specificity and functional modulation of β cells, offering translational potential for immune modulation and gene therapy in diabetes.

• Redefining DSS Colitis Models: Gateways to Next-Gen Mucosal

  2026-06-30

  This thought-leadership article reframes Dextran sulfate sodium salt (DSS, MW 35000-45000) not only as a foundation for preclinical ulcerative colitis models, but as a translational bridge to decoding and therapeutically targeting epithelial repair mechanisms. By integrating APExBIO product intelligence with the latest GPR35-KLF5 circuit insights, we provide protocol optimization, mechanistic context, and strategic guidance for translational researchers aiming to advance both pathogenesis modeling and reparative intervention design.

• Distinguishing Proliferation and Death in In Vitro Drug Resp

  2026-06-30

  Schwartz's dissertation introduces a refined analytical framework to dissect anti-cancer drug responses by distinguishing between proliferative arrest and cell death in vitro. This methodological advance enables more precise evaluation of anti-proliferative agents and apoptosis inducers, with significant implications for preclinical cancer research workflows.

16637 records 1/1110 page Next 12345 下5页 Last page